Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · EXICURE, INC. (XCUR)

Exicure gets Nasdaq extension to Dec. 2, 2026 to meet $2.5 million equity rule

Negative Impact 4 of 5 legal/regulatory Written later

Exicure received a Nasdaq extension on September 10, 2026, to regain compliance with the $2.5 million minimum stockholders' equity requirement, with a deadline of December 2, 2026. The company said the extension does not mean it has regained compliance, and failure to meet the deadline could lead Nasdaq to issue a delisting determination that the company could appeal.

Key points

  • Nasdaq notified Exicure on June 5, 2026 that it did not meet the $2.5 million minimum stockholders' equity requirement under Listing Rule 5550(b)(1).
  • Nasdaq granted an extension on September 10, 2026, through December 2, 2026, for the company to regain compliance.
  • The company must publicly demonstrate compliance on or before December 2, 2026; Nasdaq will monitor compliance through the next periodic report.
  • If the terms are not met, Nasdaq may issue a written delisting determination, which Exicure could appeal to a Nasdaq Hearings Panel.

The filing

CompanyEXICURE, INC. (XCUR)
Form8-K, current report
Filed with the SECSep 16, 2026, 10:27 AM ET
Accession number0001193125-26-392654

Items reported: 3.01 Delisting / Listing Rule Notice

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.